Bharat Biotech & Partners develop an indegenous rotavirus vaccine
17-Feb-2006 -
The Indian Rotavirus Vaccine Development Project (RVDP) announced encouraging results from a recent Phase I clinical trial of two live, natural reassortant, candidate rotavirus vaccines, 116E and I321, conducted in New Delhi, India. The RVDP consisting of the Department of Biotechnology (Govt. of ...
clinical trials
diarrhea
quality control
+2